A set of microRNAs coordinately controls tumorigenesis, invasion, and metastasis

Proc Natl Acad Sci U S A. 2019 Nov 26;116(48):24184-24195. doi: 10.1073/pnas.1913307116. Epub 2019 Nov 8.

Abstract

MicroRNA-mediated gene regulation has been implicated in various diseases, including cancer. This study examined the role of microRNAs (miRNAs) during tumorigenesis and malignant progression of pancreatic neuroendocrine tumors (PanNETs) in a genetically engineered mouse model. Previously, a set of miRNAs was observed to be specifically up-regulated in a highly invasive and metastatic subtype of mouse and human PanNET. Using functional assays, we now implicate different miRNAs in distinct phenotypes: miR-137 stimulates tumor growth and local invasion, whereas the miR-23b cluster enables metastasis. An algorithm, Bio-miRTa, has been developed to facilitate the identification of biologically relevant miRNA target genes and applied to these miRNAs. We show that a top-ranked miR-137 candidate gene, Sorl1, has a tumor suppressor function in primary PanNETs. Among the top targets for the miR-23b cluster, Acvr1c/ALK7 has recently been described to be a metastasis suppressor, and we establish herein that it is down-regulated by the miR-23b cluster, which is crucial for its prometastatic activity. Two other miR-23b targets, Robo2 and P2ry1, also have demonstrable antimetastatic effects. Finally, we have used the Bio-miRTa algorithm in reverse to identify candidate miRNAs that might regulate activin B, the principal ligand for ALK7, identifying thereby a third family of miRNAs-miRNA-130/301-that is congruently up-regulated concomitant with down-regulation of activin B during tumorigenesis, suggestive of functional involvement in evasion of the proapoptotic barrier. Thus, dynamic up-regulation of miRNAs during multistep tumorigenesis and malignant progression serves to down-regulate distinctive suppressor mechanisms of tumor growth, invasion, and metastasis.

Keywords: Acvr1c/ALK7; PanNETs; cancer; metastasis; microRNAs.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Activin Receptors, Type I / genetics
  • Activins / genetics
  • Algorithms
  • Animals
  • Cell Line, Tumor
  • Cell Transformation, Neoplastic*
  • Computational Biology / methods
  • Doxycycline / pharmacology
  • Gene Expression Regulation, Neoplastic* / drug effects
  • Humans
  • LDL-Receptor Related Proteins / genetics
  • Liver Neoplasms / genetics
  • Liver Neoplasms / secondary
  • Membrane Transport Proteins / genetics
  • Mice
  • MicroRNAs / genetics*
  • Neuroendocrine Tumors / genetics
  • Neuroendocrine Tumors / mortality
  • Neuroendocrine Tumors / pathology*
  • Pancreatic Neoplasms / genetics
  • Pancreatic Neoplasms / mortality
  • Pancreatic Neoplasms / pathology*
  • Prognosis
  • Receptors, LDL / genetics
  • Xenograft Model Antitumor Assays

Substances

  • LDL-Receptor Related Proteins
  • Membrane Transport Proteins
  • MicroRNAs
  • Receptors, LDL
  • SORL1 protein, human
  • Sorl1 protein, mouse
  • activin B
  • Activins
  • ACVR1C protein, human
  • Activin Receptors, Type I
  • Doxycycline

Grants and funding